Our findings have revealed as to how lung cancer cells modulate neutrophil apoptosis, PD-L1 expression, and impact on T cell functions through regulating factors, like IL-8, providing new perspectives for understanding the immune regulatory mechanisms within the lung cancer microenvironment and potentially offering clues for developing new lung cancer treatment strategies. This evidence concerns the gene CXCL8 and lung carcinoma.